Showing 1 - 10 of 25
Persistent link: https://www.econbiz.de/10015289425
This report and the accompanying Staff Working Document describe the activities of the EU's networked and collaborative system for monitoring and controlling the safety of human medicines and is focused on activities since the start of operation of new legislation in 2012 until the end of 2014,...
Persistent link: https://www.econbiz.de/10015289916
This report describes the activities of the networked and collaborative system for monitoring and controlling the safety of human medicines in the EU over a period covering three years following the start of operation of new European legislation designed to improve that system. While the...
Persistent link: https://www.econbiz.de/10015290110
This report describes the activities of the networked and collaborative system for monitoring and controlling the safety of human medicines in the EU over a period covering three years following the start of operation of new European legislation designed to improve that system. While the...
Persistent link: https://www.econbiz.de/10015290676
Member States and many stakeholders, including pharmacy organisations, have signalled a rise in shortages of medicinal products in the European Union (EU). Shortages present a major problem for the quality and continuity of patient care. At best, patients can be provided with an equivalent...
Persistent link: https://www.econbiz.de/10015320647
Persistent link: https://www.econbiz.de/10015321267
The Regulation on Health Technology Assessment (Regulation (EU) 2021/2282) HTAR establishes a framework for conducting Joint Clinical Assessments (JCA) at EU level. These assessments support member states in their national Health Technology Assessment (HTA) processes, providing a scientific...
Persistent link: https://www.econbiz.de/10015322230
The Regulation on Health Technology Assessment (Regulation (EU) 2021/2282) HTAR establishes a framework for conducting Joint Clinical Assessments (JCA) at EU level. These assessments support member states in their national Health Technology Assessment (HTA) processes, providing a scientific...
Persistent link: https://www.econbiz.de/10015322325
Persistent link: https://www.econbiz.de/10015276276
With Europe's Beating Cancer Plan, the European Commission is supporting effective cancer strategies that can prevent illness, save lives and reduce the impacts of cancer. This includes a Flagship Initiative to address cancers that can be prevented by vaccination, namely cancers caused by Human...
Persistent link: https://www.econbiz.de/10015277052